Righini, M.; Mancini, R.; Busutti, M.; Buscaroli, A. Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement. Int. J. Mol. Sci.2024, 25, 2554.
Righini, M.; Mancini, R.; Busutti, M.; Buscaroli, A. Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement. Int. J. Mol. Sci. 2024, 25, 2554.
Righini, M.; Mancini, R.; Busutti, M.; Buscaroli, A. Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement. Int. J. Mol. Sci.2024, 25, 2554.
Righini, M.; Mancini, R.; Busutti, M.; Buscaroli, A. Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement. Int. J. Mol. Sci. 2024, 25, 2554.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder but kidneys are not the only organs involved in this systemic disorder. Individuals with the condition may display additional manifestations beyond the renal system, involving liver, pancreas and brain in the con-text of cystic manifestations, while vascular system, gastrointestinal tract, bones, and cardiac valves in the context of non-cystic manifestations. Despite kidney involvement remain the main feature of the disease, thanks to new generation therapies, early diagnosis and better management of kidney related problems, a new wave of complications must be faced from clinicians who treated polycystic patients. Involvement of the liver represents the most prevalent extrarenal manifestation and grows importance in symptom burden and quality of life. Vascular abnormalities are a key factor for patients’ life expectancy and there’s still de-bate whether to screen or not to screen all patients. Arterial hypertension is often the earliest onset among polycystic patients leading to frequent cardiovascular complications. Although cardiac valvular abnormali-ties is a frequent complication, it rarely leads to relevant problems in the clinical history of polycystic pa-tients. One of the new relevant aspects concern bone disorders, that can exert a considerable influence on the clinical course of these patients. This review aims to provide the “state of art” among extrarenal mani-festation of ADPKD.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
